BRIEF-Redhill Biopharma Ltd and IntelGenx announce RIZAPORT commercialization with pharmatronic co.
Sept 21 (Reuters) - Redhill Biopharma Ltd :
* Redhill Biopharma and IntelGenx announce RIZAPORT commercialization term sheet with Pharmatronic Co. for Korea
* Pursuant to signing of definitive agreement, Co will grant Pharmatronic exclusive rights to commercialize RIZAPORT in South Korea
* Under term sheet, Co and IntelGenx are to receive an upfront payment and will be eligible to receive additional milestone payments
* Financial terms of term sheet were not disclosed Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.